25.59
Schlusskurs vom Vortag:
$26.34
Offen:
$26.38
24-Stunden-Volumen:
2.20M
Relative Volume:
1.50
Marktkapitalisierung:
$1.63B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-107.85M
KGV:
-11.58
EPS:
-2.21
Netto-Cashflow:
$-106.82M
1W Leistung:
+7.66%
1M Leistung:
+15.95%
6M Leistung:
-7.62%
1J Leistung:
-39.06%
Vera Therapeutics Inc Stock (VERA) Company Profile
Firmenname
Vera Therapeutics Inc
Sektor
Branche
Telefon
650-770-0077
Adresse
2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
Vergleichen Sie VERA mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
VERA
Vera Therapeutics Inc
|
25.59 | 1.68B | 0 | -107.85M | -106.82M | -2.21 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
383.12 | 99.25B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
591.99 | 63.46B | 14.21B | 4.46B | 3.56B | 39.68 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
453.56 | 59.27B | 2.46B | -319.09M | -52.09M | -2.47 |
![]()
ARGX
Argen X Se Adr
|
736.76 | 44.78B | 3.06B | 1.28B | 447.35M | 21.30 |
![]()
ONC
Beone Medicines Ltd Adr
|
334.40 | 37.75B | 3.81B | -644.79M | -669.77M | -6.24 |
Vera Therapeutics Inc Stock (VERA) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-08-04 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
2025-05-05 | Fortgesetzt | H.C. Wainwright | Buy |
2025-02-04 | Eingeleitet | Wolfe Research | Outperform |
2025-01-28 | Eingeleitet | Goldman | Buy |
2024-11-21 | Eingeleitet | Wells Fargo | Overweight |
2024-10-16 | Eingeleitet | Scotiabank | Sector Outperform |
2024-01-25 | Eingeleitet | Oppenheimer | Outperform |
2024-01-08 | Eingeleitet | Cantor Fitzgerald | Overweight |
2023-12-18 | Eingeleitet | Raymond James | Outperform |
2023-11-10 | Hochstufung | Jefferies | Hold → Buy |
2023-08-16 | Eingeleitet | Guggenheim | Buy |
2023-01-04 | Herabstufung | Jefferies | Buy → Hold |
2023-01-04 | Herabstufung | Wedbush | Outperform → Neutral |
2022-07-12 | Eingeleitet | JP Morgan | Overweight |
2022-05-02 | Eingeleitet | H.C. Wainwright | Buy |
2022-04-19 | Eingeleitet | Wedbush | Outperform |
Alle ansehen
Vera Therapeutics Inc Aktie (VERA) Neueste Nachrichten
Voya Investment Management LLC Has $15.07 Million Holdings in Vera Therapeutics, Inc. $VERA - MarketBeat
Dow Update: How correlated is Vera Therapeutics Inc to the S P5002025 Volume Leaders & Daily Profit Maximizing Trade Tips - خودرو بانک
Dynamic Technology Lab Private Ltd Takes $326,000 Position in Vera Therapeutics, Inc. $VERA - MarketBeat
Panic Selling: Is Baidu Inc. Depositary Receipt forming a double bottomMarket Risk Summary & Low Risk Profit Maximizing Plans - خودرو بانک
Day Trade: Is Vera Therapeutics Inc stock overvalued or fairly pricedQuarterly Growth Report & Fast Entry High Yield Stock Tips - khodrobank.com
Vera Therapeutics, Inc. $VERA Shares Sold by Siren L.L.C. - MarketBeat
Quarterly Risk: What is the earnings history of Vera Therapeutics IncTrade Analysis Summary & Community Verified Trade Signals - خودرو بانک
Insider Sell: What is the earnings history of Vera Therapeutics IncJuly 2025 Sentiment & Low Risk High Reward Ideas - khodrobank.com
Woodline Partners LP Sells 201,617 Shares of Vera Therapeutics, Inc. $VERA - MarketBeat
Treasury Yields: How correlated is Vera Therapeutics Inc to the S P5002025 Dividend Review & Intraday High Probability Setup Alerts - خودرو بانک
Aug Highlights: Is Vera Therapeutics Inc stock a falling knife or bargain buyJuly 2025 Technicals & Stepwise Swing Trade Plans - khodrobank.com
Patterns Watch: Will Vera Therapeutics Inc stock hit new highs in YEARVolume Spike & Stepwise Entry/Exit Trade Alerts - خودرو بانک
Weekly Earnings: Is Mistras Group Inc. vulnerable to short sellersQuarterly Investment Review & AI Driven Stock Reports - خودرو بانک
Trexquant Investment LP Buys 40,913 Shares of Vera Therapeutics, Inc. $VERA - MarketBeat
Cinctive Capital Management LP Sells 87,182 Shares of Vera Therapeutics, Inc. $VERA - MarketBeat
Northern Trust Corp Trims Position in Vera Therapeutics, Inc. $VERA - MarketBeat
Samlyn Capital LLC Sells 683,797 Shares of Vera Therapeutics, Inc. $VERA - MarketBeat
Vera Therapeutics (VERA) Stock Surges 27% Over Last Month - Sahm
How cyclical is Vera Therapeutics Inc.’s revenue streamWeekly Stock Summary & Free Technical Confirmation Trade Alerts - Lancaster City Council
EFG Asset Management North America Corp. Grows Stake in Vera Therapeutics, Inc. $VERA - MarketBeat
Can Traders Expect Breakout From Vera Therapeutics Inc. This WeekJuly 2025 Highlights & Advanced Technical Analysis Signals - beatles.ru
Vera Therapeutics Inc. Breaks Losing Streak — Is the Trend Reversing2025 Pullback Review & Weekly Momentum Stock Picks - beatles.ru
Vera Therapeutics Inc. Stock Lags Behind Sector Benchmarks2025 Institutional Moves & High Accuracy Trade Signal Alerts - beatles.ru
Parkman Healthcare Partners LLC Acquires New Stake in Vera Therapeutics, Inc. $VERA - MarketBeat
Vera Therapeutics, Inc. (NASDAQ:VERA) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Can trapped investors hope for a rebound in Vera Therapeutics Inc.Bull Run & Weekly High Momentum Picks - Newser
Published on: 2025-09-06 12:58:31 - Newser
How to build a dashboard for Vera Therapeutics Inc. stockMarket Weekly Review & Momentum Based Trading Ideas - Newser
Vera Therapeutics Inc. stock trendline breakdownJuly 2025 Weekly Recap & Stepwise Entry/Exit Trade Alerts - Newser
Armistice Capital LLC Purchases 121,717 Shares of Vera Therapeutics, Inc. $VERA - MarketBeat
Chart based analysis of Vera Therapeutics Inc. trendsAnalyst Downgrade & Stock Portfolio Risk Control - Newser
Vera Therapeutics announces inducement grants under Nasdaq listing rule 5635(c)(4) - MarketScreener
Aug Action: Should I average down on Vera Therapeutics Inc. stock2025 Momentum Check & Weekly High Return Opportunities - خودرو بانک
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
85,000 Stock Options at $21.90: Vera Therapeutics Awards Inducement Grants to New Hires - Stock Titan
Is Vera Therapeutics Inc. forming a bottoming base2025 Dividend Review & Free Accurate Trade Setup Notifications - Newser
What’s next for Vera Therapeutics Inc. stock priceMarket Weekly Review & Verified Swing Trading Watchlist - Newser
Transcript : Vera Therapeutics, Inc. Presents at Cantor Global Healthcare Conference 2025, Sep-04-2025 09 - MarketScreener
Long term hold vs stop loss in Vera Therapeutics Inc.2025 Retail Activity & Fast Gain Swing Trade Alerts - Newser
Institutional scanner results for Vera Therapeutics Inc.Market Movement Recap & Accurate Entry and Exit Point Alerts - Newser
What are Vera Therapeutics Inc.’s technical support levelsJuly 2025 Earnings & Comprehensive Market Scan Insights - خودرو بانک
Can Vera Therapeutics Inc. continue delivering strong returnsQuarterly Performance Summary & Technical Confirmation Trade Alerts - خودرو بانک
Why Vera Therapeutics Inc. is moving today2025 Key Lessons & Safe Entry Trade Signal Reports - Newser
Comparing Vera Therapeutics Inc. in custom built stock radarsWeekly Gains Report & Community Verified Trade Alerts - Newser
Best data tools to analyze Vera Therapeutics Inc. stock2025 Pullback Review & Stock Portfolio Risk Management - Newser
Strategies to average down on Vera Therapeutics Inc.Forecast Cut & Daily Risk Controlled Trade Plans - Newser
Using AI based signals to follow Vera Therapeutics Inc.July 2025 Movers & Breakout Confirmation Trade Signals - Newser
Will Vera Therapeutics Inc. rebound enough to break even2025 EndofYear Setup & Expert Verified Movement Alerts - Newser
How to recover losses in Vera Therapeutics Inc. stockEarnings Recap Summary & Reliable Entry Point Trade Alerts - Newser
When is the best time to exit Vera Therapeutics Inc.July 2025 Intraday Action & Fast Gain Stock Tips - Newser
Finanzdaten der Vera Therapeutics Inc-Aktie (VERA)
Umsatz
Nettogewinn
Free Cashflow
ENV
Vera Therapeutics Inc-Aktie (VERA) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
ENRIGHT PATRICK G | Director |
Jun 24 '25 |
Buy |
22.35 |
40,607 |
907,635 |
3,596,593 |
Fordyce Marshall | PRESIDENT AND CEO |
Feb 21 '25 |
Sale |
27.89 |
10,613 |
296,032 |
213,740 |
Fordyce Marshall | PRESIDENT AND CEO |
Feb 26 '25 |
Sale |
27.65 |
9,075 |
250,882 |
204,665 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):